EDP Sciences logo
Web of Conferences logo
Search
Menu
All issues Volume 28 (2020) BIO Web Conf., 28 (2020) 02006 Full HTML
Open Access
Issue
BIO Web Conf.
Volume 28, 2020
The 3rd International Conference on Bioinformatics, Biotechnology, and Biomedical Engineering (BioMIC 2020)
Article Number 02006
Number of page(s) 7
Section Biomedical Sciences and Engineering
DOI https://doi.org/10.1051/bioconf/20202802006
Published online 17 December 2020

© The Authors, published by EDP Sciences, 2020

Licence Creative CommonsThis is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1 Introduction

Cardiovascular disease (CVD) is leading cause of disability and premature all over the world due to the formation of thrombus in the walls of blood vessels causing heart disease such as stroke, heart attack and coronary artery disease. Increasing percentage of cardiovascular cases and deaths due to thrombosis worldwide has attracted researchers to look for agents that are more recent in degrading thrombus [1–5].

Common drugs that have been used to treat thrombosis include urokinase, tissue type plasminogen activator (t-PA) and streptokinase. The drugs work by activating plasminogen and then transforming plasminogen into plasmin. This action will degrade fibrin. However, the use of these agents has been limited due to various side effects including high price, half-life issues, allergy risks and administration problem. It has urged researchers to keep seeking for fibrinolytic enzymes with better characteristics for thrombolysis treatment [2].

In the last decades, many thrombolytic agents have been identified, studied and characterized from various sources such as earthworms, snakes, fungi, and bacteria. Bacteria have the potential to produce economically valuable enzymes with several advantages, including faster growth, scale of cell production will be more easily increased, production conditions do not depend on the season, short-time required, low cost, high activity, safe and not toxic and easily manipulated genetically [4, 6, 7]. Therefore, research about anti thrombolytic agents from new fibrinolytic protease producing bacteria must be done because more effective and efficient anti thrombolytic agents are still needed.

Fibrinolytic proteases in fermented seafood products other than shrimp and fish, i.e. sea cucumber, has not been reported. Sea cucumbers, which belong to the class Holothuroidea, have been known to possess high commercial value and have long been used for food and medicine with impressive profile of valuable nutrients including proteins and minerals [8]. Therefore, it is important to conduct research on the fibrinolytic activity of bacterial strains which is isolated from sea cucumber fermentation products is interesting to do [9]. This work aimed to evaluate prospect of bacterial fibrinolytic protease enzyme from fermentation products of seafood (especially sea cucumber) as an antithrombotic agent based on literature review.

2 Methods

This systematic review was carried out to determine prospect of developing anti thrombolytic agents from fibrinolytic protease of bacteria isolated from fermented sea cucumber. It is expected that the obtained anti thrombolytic agents can be used as an alternative medicine with better economic value, high activity and safer to deal with cardiovascular disease in Indonesia and the world. Eligibility criteria, identification of relevant studies, study selection, and control research bias were determined following previous procedures [10].

2.1 Eligibility criteria for study

First, types of thrombolytic agents that have been used in thrombosis treatment throughout the world were summarized, including the types of bacteria producing them. Study selection was based on the following inclusion criteria: [i] studies with limited subjects for treatment applied to cardiovascular disease; [ii] published in English; [iii] studies that evaluate the knowledge and practice of treatment of cardiovascular disease throughout the world as a result of measuring to find out how widespread the use of bacteria as anti-thrombolytic agents; [iv] observational study. The publication date was limited to the last 10 years considered in the search strategy.

A summary of the use of fibrinolytic protease bacteria as anti-thrombolytic agents in Indonesia was carried out to indicate the potential of using fibrinolytic protease bacteria as thrombolytic agent. The selection of studies was carried out based on the following inclusion criteria: [i] evaluation studies using knowledge and practice of using fibrinolytic protease bacteria in the treatment of cardiovascular disease as an outcome measure in Indonesia. [ii] subjects related to treatment using fibrinolytic protease bacteria in Indonesia are applied for cardiovascular disease; [iii] published in both languages namely Indonesian and English; [iv] observational studies. As part of the search strategy, the year of publication is also limited to the last 10 years.

2.1.1 Identification of relevant studies

This literature review was carried out in both manual and non-manual ways based on previous protocol [10-11]. A search for relevant studies was conducted in 2 categories: 1. Enzyme fibrinolytic proteases from fermented foods. 2. Purification and characterization of fibrinolytic protease enzymes. For the first category, electronic literature and initial manual searching through PubMed and Science Direct Database as well as manual searches regardless of publication date were carried out using the term MESH-- fibrinolytic enzyme protease; enzymes; endopeptidases; seafood; fermentation; thrombolysis therapy; sea cucumber; holothurian. Full text of all articles was extracted by electronics and manual searches from PubMed and Science Direct. The studies released from this review were: [i] studies conducted after 2010 [ii] studies of fibrinolytic protease enzymes isolated from groups of bacteria in fermented products in Indonesia; [iii] reviews; [iv] study of important fibrinolytic enzymes in thrombolysis [v] study of fibrinolytic enzyme- producing bacteria [vi] study of fibrinolytic enzyme- producing bacteria in food products. For the second category, computerized literature searches through PubMed (National Center for Biotechnology Information 2019), Science Direct (Scopus 2019) and Web of Science (Thomson Reuters 2019), as well as manual searches regardless of date of publication are carried out using the MESH query for the treatment of thrombolytic or fibrinolytic protease enzymes from food fermented products. A variety of keywords are used in search strategies including thrombolysis therapy, fibrinolytic protease enzymes, fibrinolytic protease-producing bacteria, fibrin degradation. Various keyword combinations are created using ‘and’, ‘or’ as Boolean operators. The relevant subject matter experts and selected study authors were also contacted to obtain missing or unclear data whenever it was considered important. The studies excluded from this review were: [i] studies conducted before 2010 [ii] patents.

2.1.2 Study selection

Three authors (HF, SNE, and HM) independently identified literature that fulfil the inclusion criteria in this review. Full text articles from the remaining studies taken fulfil the inclusion criteria. Observational studies were filtered using the STROBE checklist

2.1.3 Control research bias

The following issues were included in the risk of bias or quality of assessment in this systematic review: (i) completeness of reporting information on the fibrinolytic protease enzymes produced by bacteria in food fermentation products, (ii) selective yield reporting, (iii) selection of outcome measures [practice test the ability of thrombosis agents using fibrinolytic protease bacteria applied during cardiovascular treatment in Indonesia], (iv) research design, and (v) inter-conflict conflict in conducting research. When the overall criteria were met, the risk of a reasonable bias overall was regarded low.

2.1.4 Data collection and extraction

This review had been carried out based on the established guidelines submitted by Choice Reporting Items for Systematic Review and META Analysis [PRISMA] [12]. Four writers (ARS, SD, DSZ, & NH) were responsible for extracting data from research. From each study, the predetermined data extracted included the research design, sample size, treatment of cardiovascular disease among study subjects around the world, and knowledge related to the use of microbial fibrinolytic protease-producing enzymes to deal with various cardiovascular diseases.

3 Literature review

3.1 Importance of fibrinolytic enzymes in thrombolysis

Table 1 summarises cases of Cardiovascular disease (CVD) and reported mechanism of treatment by drugs in the last decade. From the data, it can be seen that thrombolysis/ fibrinolysis treatment is still widely used to date. The known mechanism of the treatment basically utilizing drugs targeting the degradation of fibrin by plasmin activation.

Table 1

Current CVD cases and related treatment reported in the last decade

3.2 Study of bacterial diversity isolated from seafood fermented products

Studies of bacterial diversity isolated from fermented food products have been conducted in many countries, although the frequency is not as often as that isolated from other ingredients. Diversity of bacteria in fermented foods is found, most of bacteria has identified as bacteria Bacillus sp. It could be seen from Table 2 and 3 that group of bacteria that produce fibrinolytic protease enzymes applied to cardiovascular disease mostly use Bacillus sp. species bacteria. Based on 19 literatures reviewed, all of the bacteria producing fibrinolytic protease enzymes reported from all over the world in the last decade were mostly used in the treatment of cardiovascular disease (Table 2).

3.3 Fibrinolytic protease enzymes from bacteria isolated from fermentation products

Studies about diversity of fibrinolytic protease enzymes from bacteria isolated from fermented foods have been carried out in many countries although their frequency is not as often as that isolated from other ingredients. For example, Stephani (2017) reported about bacterial populations that produce fibrinolytic protease enzymes in red oncom products is carried out in Indonesia [1]. The results showed that the bacteria isolated from red oncom with fibrin degradation potential consisted of Bacillus licheniformis, B.cereus, B.licheniformis, dan B. cereus. Meanwhile, molecular analysis of a potential bacterial thrombolytic agent from Douchi-China was successfully carried out by Hu (2019) [16]. The study conducted genetic diversity analysis based on the bacterial 16S rRNA gene.

The diversity of bacteria in fermented foods brings the flexibility to find groups of fibrinolytic bacteria that produce various enzymes that are able to degrade fibrin. By conducting biodiversity study, it is expected that the bacterial group could be selected, tested and then used as a new antithrombotic agent.

Table 2

Biodiversity study on protease producing bacteria from various fermented products in the last decade

3.4 Fibrinolytic enzymes producing bacteria

Table 3 summarised biodiversity studies conducted to isolate proteolytic bacteria from various fermented foods in various countries. It was found that majority of proteolytic bacteria isolated from fermented foods belong to Bacillus group. It is also confirmed by data in Table 2 and 3 that there are no other fermented sea food products other than fish (catfish) and shrimp used as samples to isolate fibrinolytic enzyme producing bacteria.

Based on the summarised data, study aiming at production of fibrinolytic enzymes from bacteria isolated from fermented sea cucumber as a rich protein source is potential to be done. It offers novelty, yet potential considering that reports about sea cucumber fermentation could not been found during this review process. A scheme showing potential of fibrinolytic protease enzymes of bacteria from sea cucumber fermentation products as antithrombotic agent is presented in Figure 1.

Table 3

Fibrinolytic enzyme producing bacteria from food

thumbnail Fig. 1

Prospects for the production of antithrombotic agents in the form of protease enzymes from the results of proteolytic bacterial secretion in the fermented sea cucumber.

4 Conclusion

Based on results of this review, majority of proteolytic bacteria isolated from fermented food belong to Bacillus group. Most bacteria producing fibrinolytic proteases applied in CVD treatment are also from Bacillus group. Studies about fibrinolytic protease enzymes of bacteria from sea cucumber fermentation products offers novelty and discovery of new proteolytic enzymes potential to be used in CVD treatment.

Authors deeply thank to Ministry of Research and Technology/National Agency for Research and Innovation (Kemenristek BRIN) or Indonesian Ministry or funding this work through Master Thesis Grant 2020.

References

  • L. Stephani, R.R. Tjandrawinata, D.N. Afifah, Y. Lim, W.T. Ismaya, M.T. Suhartono, Hayati J. Biosci., 24, 3, 124-130 (2017) [CrossRef] [Google Scholar]
  • D.N. Afifah, M. Sulchan, D. Syah, Prev. Nutr. Food Sci., 19, 3, 213 (2014) [CrossRef] [PubMed] [Google Scholar]
  • K.A. Hicks, K.W. Mahaffey, R. Mehran, S.E. Nissen, S.D. Wiviott, B. Dunn, D.A. Morrow, J. Am. Coll. Cardiol., 71, 9, 1021-1034 (2018) [CrossRef] [PubMed] [Google Scholar]
  • D.B.Q. Anh, , N.T.T. Mi, P. Van Hung, Arab. J Sci. Eng., 40, 1, 23-28 (2015) [Google Scholar]
  • P. Bhatnagar, K. Wickramasinghe, J. Williams, M. Rayner, N. Townsend, Heart, 101, 15, 1182-1189 (2015) [CrossRef] [PubMed] [Google Scholar]
  • E. Kotb, Biotechnol. Prog., 31, 2, 316-324 (2015) [CrossRef] [PubMed] [Google Scholar]
  • R. Susanti, F. Fibriana, Teknologi Enzim, Yogyakarta: Andi Offset (2017). [in Bahasa Indonesia] [Google Scholar]
  • S. Bordbar, F. Anwar, N. Saari, Marine drugs, 10, 1761-1805 (2011) [Google Scholar]
  • Yao, Z., Kim, J.A., J.H. Kim, Food Sci Biotechnol., 27, 3, 765-772 (2018) [CrossRef] [PubMed] [Google Scholar]
  • S.N. Ethica, R.R. Saptaningtyas, S.I. Muchlissin, A. Sabdono, Health and Technology, 8, 4, 239-254 (2018) [Google Scholar]
  • K. Wright, C. McDaid, J. Med. Libr. Assoc.: JMLA, 99, 2, 164 (2011) [CrossRef] [Google Scholar]
  • A. Liberati, D.G. Altman, J. Tetzlaff, C. Mulrow, P.C. Gøtzsche, J.P. Ioannidis, D. Moher, PLoS medicine, 6, 7, e1000100 (2009) [CrossRef] [PubMed] [Google Scholar]
  • D.N.A. Huy, P.A. Hao, P.V. Hung, Int. Food Res. J., 23, 1 (2016) [Google Scholar]
  • B. Chen, J. Huo, Z. He, Q. He, Y. Hao, Z. Chen, Afr. J. Microbiol. Res., 7, 19, 2001-2009 (2013) [CrossRef] [Google Scholar]
  • J. Yuan, J. Yang, Z. Zhuang, Y. Yang, L. Lin, S. Wang, BMC biotechnology, 12, 1, 36 (2012) [CrossRef] [PubMed] [Google Scholar]
  • Y. Hu, D. Yu, Z. Wang, J. Hou, R. Tyagi, Y. Liang, Y. Hu, Sci. Rep., 9, 1, 9235 (2019) [CrossRef] [PubMed] [Google Scholar]
  • F. Nailufar, R.R. Tjandrawinata, M.T. Suhartono, Adv. Pharmacol. Sci., 2016 (2016) [Google Scholar]
  • C.T. Chang, P.M. Wang, Y.F. Hung, Y.C. Chung, Food Chemistry, 133, 4, 1611-1617 (2012) [Google Scholar]
  • D. Choi, W.S. Cha, N. Park, H.W. Kim, J.H. Lee, J.S. Park, S.S. Park, Bioresour. Technol., 102, 3, 3279-3285 (2011) [Google Scholar]
  • Y. Devaraj, S.K. Rajender, P.M. Halami, Prep. Biochem. Biotech., 48, 2, 172-180 (2018) [CrossRef] [Google Scholar]
  • X. Liu, N.K. Kopparapu, Y. Li, Y. Deng, X. Zheng, Int. J. Biol. Macromol., 94, 793-801 (2017) [CrossRef] [PubMed] [Google Scholar]
  • D.W. Kim, J.H. Choi, S.E. Park, S. Kim, K. Sapkota, S.J. Kim, Int. J. Biol. Macromol., 72, 1159-1167 (2015) [CrossRef] [PubMed] [Google Scholar]
  • X. Wei, M. Luo, L. Xu, Y. Zhang, X. Lin, P. Kong, H. Liu, J. Agric. Food Chem., 59, 8, 3957-3963 (2011) [Google Scholar]
  • S.J. Jeong, K. Heo, J.Y. Park, K.W. Lee, J.Y. Park, S.H. Joo, J.H. Kim, J. Microbiol. Biotechnol, 25, 1, 89-97 (2015) [Google Scholar]
  • P. Vijayaraghavan, P. Vincent, S. Gnana, BioMed research international, 2014 (2014) [Google Scholar]
  • X. Zhang, L.J. Yun, L.B. Peng, Y. Lu, K.P. Ma, F. Tang, J. Huazhong U. Sci.-Med. [Medical Sciences], 33, 1, 153-158 (2013) [Google Scholar]
  • K. Heo, K.M. Cho, C.K. Lee, G.M. Kim, J.H. Shin, J.S. Kim, J.H. Kim, J. Microbiol. Biotechnol, 23, 7, 974-983 (2013) [Google Scholar]
  • H.D. Jo, H.A. Lee, S.J. Jeong, J.H. Kim, J. Microbiol. Biotechnol, 21, 11, 1166-1173 (2011) [Google Scholar]
  • A.A. Prihanto, M. Firdaus, J. Microbiol. Biotechnol. Food Sci., 2, 5, 2291 (2013) [Google Scholar]
  • H.H. Jeon, J.Y. Jung, B.H. Chun, M.D. Kim, S.Y. Baek, J.Y. Moon, C.O. Jeon, J. Microbiol. Biotechnol., 26, 666-674 (2016) [Google Scholar]
  • Z. Yao, X. Liu, J.M. Shim, K.W. Lee, H.J. Kim, J.H. Kim, J Microbiol. Biotechn., 27, 1, 9-18 (2017) [CrossRef] [Google Scholar]
  • M.A. Almalki, D.S.D. Dhas, P. Vijayaraghavan, J. Sci. Res. 16, 2, 1-8 (2017) [Google Scholar]
  • D.A. Lestari, Isolasi Bakteri Penghasil Enzim Protease Pada Oncom Merah Pasca Fermentasi 72 Jam dan Identifikasi Molekuler Bakteri Berbasis Gen 16S rRNA [Doctoral dissertation]. Universitas Muhammadiyah Semarang, Indonesia. (2018). [in Bahasa Indonesia] [Google Scholar]
  • W.O. Inayatul, S.I. Muchlissin, A.H. Mukaromah, S. Darmawati, S.N. Ethica, Isolasi dan Identifikasi Molekuler Bakteri Penghasil Enzim Protease Pseudomonas stutzeri ISTD4 dari Tempe Gembus Pasca Fermentasi 1 Hari. In Prosiding Seminar Nasional & Internasional, 1, 1, (2018). [in Bahasa Indonesia] [Google Scholar]
  • R. Safitri, S.I. Muchlissin, A.H. Mukaromah, S. Darmawati, S.N. Ethica. Isolasi Bakteri Penghasil Enzim Protease Bacillus thuringiensis IRODI Pada Oncom Merah Pasca Fermentasi 24 Jam. Seminar Nasional Edusainstek. (2019), pp. 62-69 [in Bahasa Indonesia] [Google Scholar]
  • A. Harun, S.I. Muchlissin, A.H. Mukaromah, S. Darmawati, S.N. Ethica. Isolasi Bakteri Penghasil Enzim Protease Staphylococcus hominis Pada Oncom Merah Pasca Fermentasi 120 Jam. In Prosiding Seminar Nasional & Internasional, 1, 1, (2018). [in Bahasa Indonesia] [Google Scholar]
  • N.A. Japri, A.R. Sulistyaningtyas, S. Darmawati, S.N. Ethica, Isolasi dan Identifikasi Molekuler Bakteri Proteolitik Staphylococcus cohnii Strain IRLV5 pada Rusip Udang Putih (Litopeaneus Vannamei) Pasca Fermentasi 120 Jam Berdasarkan Analisis Gen 16s rRNA. In Prosiding Seminar Nasional Mahasiswa Unimus (Vol. 2), (2019). [in Bahasa Indonesia] [Google Scholar]
  • M. Fazri, A.I. Kartika, S. Darmawati, S.N. Ethica, Isolasi dan Identifikasi Molekuler Bakteri Staphylococcus epidermis pada Rusip Udang Windu (Penaeus monodon) Pasca Fermentasi 24 Jam Berdasarkan Sekuen Gen 16S rRNA. In Prosiding Seminar Nasional Mahasiswa Unimus (Vol. 2), (2019). [in Bahasa Indonesia] [Google Scholar]

All Tables

Table 1

Current CVD cases and related treatment reported in the last decade

In the text
Table 2

Biodiversity study on protease producing bacteria from various fermented products in the last decade

In the text
Table 3

Fibrinolytic enzyme producing bacteria from food

In the text

All Figures

thumbnail Fig. 1

Prospects for the production of antithrombotic agents in the form of protease enzymes from the results of proteolytic bacterial secretion in the fermented sea cucumber.
In the text

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.